BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29355432)

  • 21. Head and neck manifestation and prognosis of Langerhans' cell histiocytosis in children.
    Nicollas R; Rome A; Belaïch H; Roman S; Volk M; Gentet JC; Michel G; Triglia JM
    Int J Pediatr Otorhinolaryngol; 2010 Jun; 74(6):669-73. PubMed ID: 20363036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of multisystem Langerhans cell histiocytosis (histiocytosis X) with etoposide.
    Yu LC; Shenoy S; Ward K; Warrier RP
    Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):275-7. PubMed ID: 8037350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment for multisystem Langerhans' cell histiocytosis.
    Katz BZ
    J Pediatr; 2002 Feb; 140(2):280. PubMed ID: 11865293
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
    Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
    Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X).
    Broadbent V; Pritchard J; Yeomans E
    Med Pediatr Oncol; 1989; 17(2):97-100. PubMed ID: 2784842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study.
    Ng Wing Tin S; Martin-Duverneuil N; Idbaih A; Garel C; Ribeiro M; Parker JL; Defachelles AS; Lambilliotte A; Barkaoui M; Munzer M; Gardembas M; Sibilia J; Lutz P; Fior R; Polak M; Robert A; Aumaitre O; Plantaz D; Armari-Alla C; Genereau T; Berard PM; Talom GN; Pennaforte JL; Le Pointe HD; Barthez MA; Couillault G; Haroche J; Mokhtari K; Donadieu J; Hoang-Xuan K;
    Orphanet J Rare Dis; 2011 Dec; 6():83. PubMed ID: 22151964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Childhood Langerhans cell histiocytosis with severe lung involvement: a nationwide cohort study.
    Le Louet S; Barkaoui MA; Miron J; Galambrun C; Aladjidi N; Chastagner P; Kebaili K; Armari-Alla C; Lambilliotte A; Lejeune J; Moshous D; Della Valle V; Sileo C; Ducou Le Pointe H; Chateil JF; Renolleau S; Piloquet JE; Portefaix A; Epaud R; Chiron R; Bugnet E; Lorillon G; Tazi A; Emile JF; Donadieu J; Héritier S
    Orphanet J Rare Dis; 2020 Sep; 15(1):241. PubMed ID: 32907615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclosporine A therapy for multisystem langerhans cell histiocytosis.
    Minkov M; Grois N; Broadbent V; Ceci A; Jakobson A; Ladisch S
    Med Pediatr Oncol; 1999 Nov; 33(5):482-5. PubMed ID: 10531573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed Treatment Response in a Neonate with Multisystem Langerhans Cell Histiocytosis Case report and review of literature.
    Singh A; Mandal A; Singh L; Mishra S; Patel A
    Sultan Qaboos Univ Med J; 2017 May; 17(2):e225-e228. PubMed ID: 28690898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Langerhans-cell histiocytosis--excellent response to etoposide.
    Mayou SC; Chu AC; Munro DD; Plowman N
    Clin Exp Dermatol; 1991 Jul; 16(4):292-4. PubMed ID: 1794174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study.
    Donadieu J; Bernard F; van Noesel M; Barkaoui M; Bardet O; Mura R; Arico M; Piguet C; Gandemer V; Armari Alla C; Clausen N; Jeziorski E; Lambilliote A; Weitzman S; Henter JI; Van Den Bos C;
    Blood; 2015 Sep; 126(12):1415-23. PubMed ID: 26194764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of children younger than 24 months with langerhans cell histiocytosis and bone involvement: a report from a single institution.
    Kamath S; Arkader A; Jubran RF
    J Pediatr Orthop; 2014 Dec; 34(8):825-30. PubMed ID: 25387157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orbital involvement in langerhans cell histiocytosis.
    Vosoghi H; Rodriguez-Galindo C; Wilson MW
    Ophthalmic Plast Reconstr Surg; 2009; 25(6):430-3. PubMed ID: 19935242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Langerhans' cell histiocytosis (LCH) in adolescence presented with central diabetes insipidus: a case report.
    Niramitmahapanya S; Deerochanawong C; Suwanbun T; Serirat O; Utrapichart U; Kalayanarooj S; Kuakpaetoon T
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S135-9. PubMed ID: 21717893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II trial using thalidomide for Langerhans cell histiocytosis.
    McClain KL; Kozinetz CA
    Pediatr Blood Cancer; 2007 Jan; 48(1):44-9. PubMed ID: 16333818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypofibrinogenemia in a girl with Langerhans cell histiocytosis during etoposide and prednisolone therapy.
    Miura T; Nakamura M; Tsunematsu Y; Fujimoto J; Meguro T; Yamada K
    Acta Paediatr Jpn; 1993 Apr; 35(2):148-50. PubMed ID: 8503273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Langerhans cell histiocytosis in children less than 2 years of age.
    Kusuma Kumary P; Priyakumari T; Chellam VG; James FV; Nair MK
    Indian Pediatr; 1999 Jan; 36(1):29-36. PubMed ID: 10709120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 5-Year EFS of Multisystem LCH With Risk-Organ Involvement Is Suboptimal: A Single-center Experience From India.
    Totadri S; Bansal D; Trehan A; Srinivasan R; Varma N; Kakkar N; Saxena AK; Bhatia P
    J Pediatr Hematol Oncol; 2016 Jan; 38(1):e1-5. PubMed ID: 26274033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of relapsed Langerhans cell histiocytosis by cyclosporin A combined with etoposide and prednisone.
    Körholz D; Janssen G; Göbel U
    Pediatr Hematol Oncol; 1997; 14(5):443-9. PubMed ID: 9267876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
    Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J
    Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.